Illumina: Cutting edge buy in genetics

by The Stock Advisors, Benzinga Contributor

August 15, 2011 8:00 PM | 17 seconds read | Make a Comment

by Mark Skousen, editor Hedge Fund Trader

Our newest recommendation is a cutting-edge medical technology company.

Illumina

(

) is the world leader in one of the biggest growth areas in the health care industry: genetic sequencing and analysis.

Posted In: Trading Ideas illumina

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.